Financhill
Back

Morphic Holding Quote, Financials, Valuation and Earnings

Morphic Holding Price Quote

$56.51
-0.08 (-0.14%)
(Updated: July 23, 2024 at 6:55 PM ET)

Morphic Holding Key Stats

Buy
93
Morphic Holding (MORF) is a Buy

Day range:
$56.46 - $56.59
52-week range:
$19.35 - $62.08
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
38.07
P/B ratio:
4.27%

Volume:
1.5M
Avg. volume:
3.8M
1-year change:
-0.49%
Market cap:
$2.8B
Revenue:
$521K
EPS:
$-3.5

How Much Does Morphic Holding Make?

Data Unavailable

Is Morphic Holding Growing As A Company?

Data Unavailable

Morphic Holding Stock Price Performance

  • Did Morphic Holding Stock Go Up Last Month?
    Morphic Holding share price went up by 98.77% last month
  • Did MORF's Share Price Rise Over The Last Year?
    MORF share price fell by -0.49% over the past 1 year

What Is Morphic Holding 52-Week High & Low?

Morphic Holding Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Morphic Holding?

  • How Much Debt Does Morphic Holding Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Morphic Holding Have?
    Cash and short term investments quarterly total is $658.8M
  • What Is Morphic Holding’s Book Value Per Share?
    Book value per share is 13.25

Is Morphic Holding Cash Flow Positive?

  • What Is MORF Cash Flow From Operations?
    Cash flow from operations (TTM) is -$127.2M
  • What Is Morphic Holding’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $351.9M
  • What Is Morphic Holding’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$222M

Morphic Holding Return On Invested Capital

Data Unavailable

Morphic Holding Earnings Date & Stock Price

Morphic Holding Competitors

  • Who Are Morphic Holding's Competitors?
    Below is a list of companies who compete with Morphic Holding or are related in some way:
    • Alimera Sciences Inc (ALIM)
    • Alnylam Pharmaceuticals Inc (ALNY)
    • IDEAYA Biosciences Inc (IDYA)
    • Eli Lilly and Co (LLY)
    • Pulse Biosciences Inc (PLSE)

Morphic Holding Dividend Yield

Data Unavailable

Morphic Holding Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 5.51%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 7
Sell Recommendations: 0
Price Target: 56.88
Upside from Last Price: 0.5%

Major Shareholders

  • How many MORF shares are owned by institutional investors?
    79.1M MORF shares are owned by institutional investors
  • How many MORF shares are owned by insiders?
    5.1M MORF shares are owned by insiders